Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  aclarubicin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 38 for your search:
Start Over
Phase I-II Chemotherapy with Aclacinomycin-A for Advanced Colorectal Adenocarcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MDA-DT-8125, NCI-W81-0420
Phase I-II Chemotherapy with Oral Aclacinomycin for Refractory Cancer of Breast, Ovary, Testis, and Lung, and Malignant Lymphoma (Summary Last Modified 07/97)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-81-C-116, NCI-MB-162
Phase II Pilot Chemotherapy with Aclacinomycin in Patients with Advanced Ovarian Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-039-464
Phase II Chemotherapy with Aclacinomycin with or without Adriamycin for Advanced Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCT-1280
Phase II Chemotherapy with Aclacinomycin-A for Renal Cell Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: WSU-C-40981
Phase II Chemotherapy with Aclacinomycin-A for Squamous Cell Carcinoma of the Head and Neck
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: WSU-C-41081
Phase II Combination Chemotherapy with ACM-A/VP-16 in Patients with Refractory ALL
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: URCC-2482M, NCI-T83-0984D, T83-0984
Phase II Chemotherapy with Aclacinomycin-A for Advanced, Measurable Gastric Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-039-204
Phase II Chemotherapy with Weekly Aclacinomycin for Stage III/IV Metastatic Breast Carcinoma Previously Treated with Nonanthracycline Agents
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-BRE-81209
Phase II Chemotherapy with Aclacinomycin Every 3 Weeks for Metastatic Breast Carcinoma Previously Treated with Nonanthracycline Agents
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-BRE-81210
Phase II Chemotherapy with Aclacinomycin in Previously Untreated Patients with Advanced Stage III/IV Soft Tissue Sarcomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: SEG-SAR-81237
Phase II/III Single-Agent Chemotherapy Comparing Two Schedules of Aclacinomycin-A for Advanced or Recurrent Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI
Protocol IDs: SWOG-8206
Phase II Master Protocol for Recurrent or Metastatic Sarcomas and Mesotheliomas --- Alpha-2-Interferon
Phase: Phase II
Type: Treatment
Status: Closed
Age: 14 and over
Sponsor: NCI
Protocol IDs: EST-2781
Phase II Master Protocol to Evaluate New Agents for Advanced non-Small Cell Bronchogenic Carcinoma --- DHAD vs ACM-A vs AZQ
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3581
Phase II Master Protocol to Evaluate New Agents for Refractory Small Cell Bronchogenic Carcinoma --- ACM-A vs AZQ (Summary Last Modified 06/97)
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4581
Phase II Master Protocol Chemotherapy for Metastatic or Recurrent Gastric Cancer --- VP-16 vs DHAD (Summary Last Modified 06/97).
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-5282
Phase II Chemotherapy with ACM-A for Unresectable, Disseminated Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCT-1381
Phase II Chemotherapy with ACM-A for Squamous Cell Carcinoma of the Head and Neck
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCT-2581
Phase II Chemotherapy with Aclacinomycin-A for Advanced Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: OSU-IOU-8210, NCI-W83-0066, W83-0066
Phase II Pilot Evaluation of ACM-A as a 24-Hour Continuous Infusion for Metastatic non-Small Cell Carcinoma of the Lung
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-DT-8106A, NCI-C82-1314
Phase II Chemotherapy with Aclacinomycin-A for Recurrent or Extensive Small Cell and non-Small Cell Carcinoma of the Lung
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-LUN-82256
Phase II Chemotherapy with ACM-A for Refractory Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-MM-82272, SEG-MM-82-272
Phase II Chemotherapy with Aclacinomycin-A for Refractory Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8213
Pilot Phase II Chemotherapy with Aclacinomycin-A in Adults with AML or ALL in Relapse
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: SWOG-8262
Start Over